RA CAPITAL MANAGEMENT, L.P. - 29 Sep 2025 SCHEDULE 13D/A Report for ARS PHARMACEUTICALS, INC. Common Stock, par value $0.0001 per share (SPRY)

Filing Manager
RA CAPITAL MANAGEMENT, L.P.
Reporting Manager
RA Capital Management, L.P.
Security
ARS PHARMACEUTICALS, INC. Common Stock, par value $0.0001 per share
Symbol
SPRY
Shares outstanding
98,567,360 shares
Disclosed Ownership
10,940,977 shares
Ownership
11.1%
Form type
SCHEDULE 13D/A
Filing time
01 Oct 2025, 21:19:13 UTC
Date of event
29 Sep 2025
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
RA Capital Management, L.P. 11.1% 10,940,977 0 10,940,977 /s/ Peter Kolchinsky By Peter Kolchinsky, Authorized Signatory 0001346824
Peter Kolchinsky 11.1% 10,940,977 0 10,940,977 /s/ Peter Kolchinsky Peter Kolchinsky 0001384859
Rajeev Shah 11.1% 10,940,977 0 10,940,977 /s/ Rajeev Shah Rajeev Shah 0001619841
RA Capital Healthcare Fund, L.P. 10.1% 9,958,073 0 9,958,073 /s/ Peter Kolchinsky By RA Capital Healthcare Fund GP, LLC, its General Partner, By Peter Kolchinsky, Manager 0001315082